Navigation Links
Seahorse Bioscience, Inc. Acquires BioProcessors Corp.

Market Vision, Engineering Know-how, and Smart Plastics Expertise Combine

to bring Practical Cell Technologies to the Life Sciences

N. BILLERICA, Mass., March 9 /PRNewswire/ -- Seahorse Bioscience, Inc., manufacturer of instruments and consumables for cell based metabolic assays today announced the acquisition of BioProcessors Corp., manufacturer of systems for optimizing biologic drug manufacturing. The two companies will be integrated and operate under the Seahorse name.

A concurrent $6MM financing included Commonwealth Capital, Oxford Bioscience, Flagship Ventures, Life Sciences Partners, FLIR Systems Inc, Healthcare Ventures, New Science Ventures and HLM Venture Partners.

Seahorse applies its expertise in engineering and biology to modernize cell-based science using "smart plastic" consumables and easy to use instruments. Its XF series instruments measure energy consumption and mitochondrial function in cells in a 24 or 96 well microplate with precision and throughput far better than any previous technology. It has enabled new insights into the metabolic deficiencies underlying many neurological diseases, obesity, diabetes, cancer and cardiovascular disease, as well as an early indication of potential toxicities of candidate drug compounds.

The BioProcessors "SimCell" technology modernizes biologic drug manufacturing scale-up and optimization using plastic, microplate-sized cards with six small bioreactors. One technician can run tens, hundreds or even 1,000 simultaneous experiments for weeks or months to select clones, optimize medium, or determine the best process conditions for protein manufacturing. The system offers Biopharmaceutical and CMO customers a strong competitive advantage in developing and optimizing production of biologic products from mammalian cell culture.

"Both the XF and SimCell technologies have reached a key milestone where thought-leading customers have demonstrated their value," said Jay Teich, CEO. "Our sales of XF series instruments tripled in 2008, and we introduced three new products to this market at the end of the year. With the addition of the people and technologies of BioProcessors Corp., we will expand and grow the SimCell product line and markets during the coming year."

"Seahorse hit the nail on the head with its XF96 instrument and their business has grown steadily. We believe that the SimCell technology will fuel continued growth in the years to come," said Jeff Hurst of Commonwealth Capital.

"We have supported BioProcessors through their development and customer validation of the SimCell technology. We now look forward to participating in a strong company with complementary product lines and a growing worldwide market presence," said Fouad Azzam of Life Sciences Partners.

Liberty Tree Advisors, LLC acted as financial advisor to Seahorse Bioscience.

About Seahorse Bioscience

Seahorse XF instruments have become the new standard in cellular bioenergetic measurements. Scientists worldwide use these tools to advance their research in understanding the role of mitochondrial function in obesity, diabetes, ageing, cancer, cardiovascular function and safety toxicity. Founded in 2001, Seahorse is headquartered in Billerica, MA. For more information, please visit

    Media Contact: Cynthia Egan
    Phone: 978.671.1610

SOURCE Seahorse Bioscience, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Seahorse Bioscience Appoints Former Molecular Devices Executive Dr. Joseph D. Keegan to Board of Directors
2. Seahorse Bioscience Receives Poster Award from the European Association for the Study of Obesity
3. Todd R. Nelson Named Chief Executive Officer of eBioscience, Inc.
4. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
5. Neogen Acquires Kane Enterprises
6. OncoVista, Inc. Closes on $6.8 Million Financing and Acquires Control of a Public Shell Company
7. Thermo Fisher Scientific Acquires Instrument Sales Business of Davis Inotek
8. United BioSource Acquires Interest in Leading Adaptive Design Technology Service Provider
9. NSF International Acquires David Begg Associates
10. United BioSource Acquires Caro Research, Leader in Simulation Modeling
11. Respironics Acquires Apollo Light Systems, Inc., Expands into Circadian Rhythm Device-Based Therapy Market
Post Your Comments:
(Date:10/13/2015)... SUNNYVALE, Calif. , Oct. 13, 2015  Cepheid ... the quarter ending September 30, 2015. ... financial results, total revenue for the third quarter of ... net loss per share is expected to be approximately ... financial results, non-GAAP net loss per share for the ...
(Date:10/13/2015)... Research and Markets( ) has announced ... for Bone Morphogenetic Protein Growth Factor Therapy - 16 ... --> --> Bone morphogenetic proteins ... bone after a fracture. In nature, these proteins have ... of the skeleton. There are twenty different BMPs that ...
(Date:10/13/2015)... ... October 13, 2015 , ... AxioMx ... that it has received a Phase I Small Business Innovative Research (SBIR) grant ... of General Medical Sciences (NIGMS), will fund the development of a technique to ...
(Date:10/13/2015)... 13, 2015  According to Kalorama Information, the ... $102 billion by the end of 2015. Clinical ... industry, as it is estimated that approximately 80% ... tests. In addition to diagnosing patients, clinical lab ... progression, monitor drug treatment and conditions, and determine ...
Breaking Biology Technology:
(Date:9/29/2015)... 2015 News facts: ... saving energy , Minimized design shrinks PC footprint ... Mode and embedded Fujitsu PalmSecure authentication enable enterprises to ... today shows that good things come in small packages, ... its enterprise desktop and mobile portfolio. Featuring workplace design ...
(Date:9/28/2015)... 2015 CLEAR, the leading biometric ... traveler service is coming to Austin-Bergstrom International ... a frictionless experience, serious speed and enhanced ... offers our travelers an expedited security screening ... Jim Smith , Executive Director, Austin-Bergstrom International ...
(Date:9/28/2015)... 28, 2015 The global ... USD 12.03 billion by 2020, growing at a CAGR ... as Backside Illumination (BSI) technique to improve picture quality ... period.      (Logo: , ... to reduce loss and, thus, reduce the noise interference ...
Breaking Biology News(10 mins):